FFRct vs prolaio eVO2peak Module
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
FFRct provides a non-invasive diagnostic analysis of coronary arteries from CCTA scans to aid in diagnosing coronary artery disease and guiding treatment. The prolaio eVO2peak Module, conversely, estimates peak oxygen consumption using data from wearable sensors to assist in cardiovascular evaluation and research. While both leverage AI in cardiology, their distinct data inputs and specific clinical applications make them complementary tools rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis is a non-invasive AI-powered diagnostic tool that creates personalized 3D models of coronary arteries from CCTA scans to assess blood flow and aid in diagnosing coronary artery disease (CAD). It helps guide treatment strategies and revascularization decisions. The prolaio eVO2peak Module estimates peak oxygen consumption (eVO2peak) using real-world patient data for cardiovascular research and care, serving as an adjunctive aid in clinical evaluation.
HeartFlow FFRct Analysis utilizes data from CCTA scans to generate its insights. The prolaio eVO2peak Module processes demographic data, single-lead ECG, and triaxial accelerometry inputs from qualified third-party FDA-cleared wearable medical sensors.
FFRct Analysis generates personalized 3D digital models of coronary arteries, analyzes blood flow, and identifies areas of narrowing using FFRct values to aid in CAD diagnosis. The prolaio eVO2peak Module provides an estimation of peak oxygen consumption (eVO2peak).
HeartFlow FFRct Analysis is designed to support Cardiology and Radiology specialties. The prolaio eVO2peak Module supports Cardiology, Physical Medicine & Rehab, and Sports Medicine specialties.